Influencing factors of APCA. by Wenping Ning (19871091)

Subjects:

Temporal trends in APCA. by Wenping Ning (19871091)

Subjects:

Traditional Markov transfer probability matrices. by Wenping Ning (19871091)

Subjects:

Spatial Markov transfer probability matrix. by Wenping Ning (19871091)

Subjects:

Three-dimensional kernel density of APCA. by Wenping Ning (19871091)

Subjects:

Spatial distribution of EAI (Map from the Ministry of Natural Resources of China, cartographic license: GS (2020) 4619). by Wenping Ning (19871091)

Subjects:

Spatial distribution of APCA (Map from the Ministry of Natural Resources of China, cartographic license: GS (2020) 4619). by Wenping Ning (19871091)

Subjects:

Spatial distribution of SAI (Map from the Ministry of Natural Resources of China, cartographic license: GS (2020) 4619). by Wenping Ning (19871091)

Subjects:

Fixed effects and panel quantile regression results. by Wenping Ning (19871091)

Subjects:

Study area (Map from the Ministry of Natural Resources of China, cartographic license: GS (2020) 4619). by Wenping Ning (19871091)

Subjects:

The APCA, SAI and EAI data of the eight main producing provinces in China. by Wenping Ning (19871091)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Census Regions in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Overall population and Sex in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Racial groups in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Superimposition of the cephalometric tracings obtained before and after treatment of case with premolar tooth extraction. by Lijuan Liu (136685)

Subjects: